Showing results (131-140 of 177) with videos related to
Sort By:
Pageof 18
Journal of Neurotrauma|September 24, 2011
Spinal cord injury triggers an intrinsic growth-promoting state in nociceptorsSupinder S Bedi, Michael T Lago, Luke I Masha, et al.Pediatric Surgery International|May 3, 2005
The effect of short-chain fatty acids butyrate, propionate, and acetate on urothelial cell kinetics in vitro: potential therapy in augmentation cystoplastyJ P Dyer, J M Featherstone, L Z Solomon, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 2015
The Periaqueductal Gray Orchestrates Sensory and Motor Circuits at Multiple Levels of the NeuraxisStella Koutsikou, Thomas C Watson, Jonathan J Crook, et al.The Journal of Urology|November 19, 2015
Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic SyndromesJ Curtis Nickel, Ian W Mills, Tim J Crook, et al.Environmental Entomology|April 19, 2008
Development of a host-based semiochemical lure for trapping emerald ash borer Agrilus planipennis (Coleoptera: Buprestidae)Damon J Crook, Ashot Khrimian, Joseph A Francese, et al.The Journal of Physiology|March 19, 2014
Neural substrates underlying fear-evoked freezing: the periaqueductal grey-cerebellar linkStella Koutsikou, Jonathan J Crook, Emma V Earl, et al.Journal of Pediatric Urology|March 16, 2012
Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladderBimal Malhotra, Ahmed El-Tahtawy, Ellen Q Wang, et al.Urology|September 27, 2012
Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndromeJ Curtis Nickel, Gary Atkinson, John N Krieger, et al.Frontiers in Neural Circuits|May 1, 2013
The olivo-cerebellar system and its relationship to survival circuitsThomas C Watson, Stella Koutsikou, Nadia L Cerminara, et al.Journal of Pediatric Urology|December 12, 2022
Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 studyTakeya Kitta, Amanda Darekar, Bimal Malhotra, et al.Pageof 18